Acadia Pharmaceuticals buy TD Cowen
Start price
26.02.26
/
50%
€20.68
Target price
26.02.27
€31.31
Performance (%)
-13.37%
Price
16.04.26
€18.04
Summary
This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -13.37%. This prediction currently runs until 26.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -5.376% | -5.376% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by TD_Cowen for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its price target raised by TD Cowen from $35.00 to $37.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by TD_Cowen for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.54
11.09.25
11.09.25
€33.34
11.09.26
11.09.26
-12.78%
16.04.26
16.04.26
